Replies to post #15225 on Cytodyn Inc (CYDY)

[fred198484]

One potential unexpected positive that could help them raise the needed funds would be for the Mono trial to be enrolled much faster than anyone expects it to be. It should be much easier to enroll for that trial and they seem to have been making good progress with it. What if they announce it will be fully enrolled by August or something like that. It could make a huge difference for the upcoming fund raise and I suspect such a surprise is not out of the question. Since Mono is where this company will make its money, this is where they should be spending the most effort. They are only going to use the combo results to push the Mono therapy and yet I think we all have been looking at it the other way around.

At the same time, you should expect a very large raise that will be very dilutive if this is correct. After that fund raising, depending on how much they raise, the company might well be a decent investment opportunity.

[trding]

Wow, when by the time I finished my post you had beat me to it... it took me a few minutes.

[Amatuer17]

Not the cc but LD micro conf

http://wsw.com/webcast/ldmicro12/register.aspx?conf=ldmicro12&page=cydy&url=http://wsw.com/webcast/ldmicro12/cydy/index.aspx

Hear the presentation - @13.30 min minutes and later he reiterates timing

See the last slide of the deck - study completion in 2018

http://content.equisolve.net/cytodyn/media/a142a8575db88331c0585a336ca2ebfd.pdf

[Bobbyinvest]

Dr. M, I am optimistic that we can get combo done in Q2, and mono rolling this year but perhaps from past performance It wouldn't surprise me if the mono trial enrollment was not complete in sometime 2018. I am sure they would need to enhance the company capital before they can fully commit to having hundreds of patients enrolled all at once since this would be very expensive endeavor.